RYTM 13F Hedge Fund and Asset Management Owners

Data as of 2020-11-22
Market Cap	944.655 Million	Shares Outstanding	44.205 Million	Avg 30-day Volume	215.926 Thousand
P/E Ratio	-7.1	Dividend Yield		EPS	-2.99
Price/Sales		Price cash flow ratio		Price free cash flow ratio	-7.5
Book Value	4.46	Price to Tangible Book	4.8	Alpha	-0.0
Short Interest Ratio		% Short Interest to Float		R-squared	0.163994
BETA	1.27991	52-week High/Low	32.24 / 12.99	Stddev	0.162879

Q3 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	2	2	0.0%	1 (0.07%)	1 (0.06%)	0.0%
Funds Holding:	113	91	24.18%	28 (1.84%)	24 (1.56%)	16.67%
13F shares:	39.048 Million	41.008 Million	-4.78%	15.903 Million	17.346 Million	-8.32%
% Ownership	88.5075	92.9488	-4.78%	36.0453	39.316	-8.32%
New Positions:	31	21	47.62%	9	6	50.0%
Increased Positions	25	38	-34.21%	6	10	-40.0%
Closed Positions	9	10	-10.0%	5	4	25.0%
Reduced Positions	37	18	105.56%	11	6	83.33%
Total Calls	41.537 Thousand	100	41437.0%	20.2 Thousand
Total Puts	87.103 Thousand	0		28 Thousand
PUT/CALL Ratio	2.1	0.0		1.39
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding RYTM (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RYTM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
CHIEN JENNIFER EVP, HEAD OF NORTH AMERICA	Officer	0	2020-11-09	2
MAZABRAUD YANN EVP, HEAD OF INTERNATIONAL	Officer	0	2020-10-05	2
DESIKAN NITHYA CHIEF COMMERCIAL OFFICER	Officer	43,602	2020-08-31	5
SMITH HUNTER C CHIEF FINANCIAL OFFICER	Officer	0	2020-07-20	6
MEEKER DAVID P PRESIDENT AND CEO	Officer Director	0	2020-07-20	2
KELNER SIMON CHIEF HUMAN RESOURCES OFFICER	Officer	0	2020-06-30	2
STEWART MURRAY CHIEF MEDICAL OFFICER	Officer	0	2020-06-30	2
RA CAPITAL MANAGEMENT, L.P. RA CAPITAL HEALTHCARE FUND LP KOLCHINSKY PETER SHAH RAJEEV M.	10% Owner	5,140,408	2020-06-30	1
FOLEY TODD	Director	1,909,258	2020-06-26	18
JEAN CHRISTOPHE	Director	0	2020-06-17	1
MCGIRR DAVID W J	Director	0	2020-06-17	1
MATHERS EDWARD T	Director	0	2020-06-17	1
GOOD JENNIFER L	Director	0	2020-06-17	1
ARBUCKLE STUART A	Director	0	2020-06-17	1
GOTTESDIENER KEITH MICHAEL CEO & PRESIDENT	Officer Director	558,250	2020-03-09	3
RA CAPITAL MANAGEMENT, LLC RA CAPITAL HEALTHCARE FUND LP KOLCHINSKY PETER	10% Owner	5,422,312	2019-10-16	0
VAN DER PLOEG LEONARDUS H.T. CHIEF SCIENTIFIC OFFICER	Officer	42,339	2019-05-30	0
THIRD ROCK VENTURES LP THIRD ROCK VENTURES GP, L.P. TRV GP, LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J	10% Owner	3,278,752	2018-08-30	0
EXTER NEIL	Director	0	2018-06-06	0
ORBIMED ADVISORS LLC ORBIMED CAPITAL GP V LLC	10% Owner SEE REMARKSSEE REMARKS	No longer subject to file	2018-05-22	0
FIEDOREK FRED T. CHIEF MEDICAL OFFICER	Officer	0	2018-02-14	0
MPM BIOVENTURES V, L.P. EVNIN LUKE GADICKE ANSBERT MPM ASSET MANAGEMENT INVESTORS BV5 LLC MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC	10% Owner	2,696,392	2017-10-10	0
ORBIMED ADVISORS LLC ORBIMED CAPITAL GP V LLC ISALY SAMUEL D	10% Owner	2,901,295	2017-10-10	0
IPSEN, S.A.	10% Owner	No longer subject to file	2017-10-10	0
PFIZER INC	10% Owner	No longer subject to file	2017-10-10	0
HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.	10% Owner	No longer subject to file	2017-10-10	0
BARRIS PETER J	10% Owner	4,909,956	2017-10-10	0
BARRETT M JAMES	10% Owner	4,909,956	2017-10-10	0
MOTT DAVID M	10% Owner	4,909,956	2017-10-10	0
KERINS PATRICK J	10% Owner	4,909,956	2017-10-10	0
BASKETT FOREST	10% Owner	4,909,956	2017-10-10	0
VISWANATHAN RAVI	10% Owner	4,909,956	2017-10-10	0
SANDELL SCOTT D	10% Owner	4,909,956	2017-10-10	0
NEW ENTERPRISE ASSOCIATES 13 LP NEA PARTNERS 13, LIMITED PARTNERSHIP NEA 13 GP, LTD	10% Owner	4,909,956	2017-10-10	0
FLYNN JAMES E DEERFIELD MGMT L.P. DEERFIELD MANAGEMENT CO DEERFIELD SPECIAL SITUATIONS FUND, L.P. DEERFIELD MGMT III, L.P. DEERFIELD PRIVATE DESIGN FUND III, L.P.	10% Owner POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP	No longer subject to file	2017-10-10	0
BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS (GP) LLC BAKER FELIX BAKER JULIAN	FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER	No longer subject to file	2017-10-05	0
SILVERSTEIN JONATHAN	Director 10% Owner	0	2017-10-04	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
CHIEN JENNIFER - Officer EVP, HEAD OF NORTH AMERICA	2020-11-10 16:07:20 -0500	2020-11-09	A	100,000		a	100,000	direct
MAZABRAUD YANN - Officer EVP, HEAD OF INTERNATIONAL	2020-10-06 16:10:44 -0400	2020-10-05	A	100,000		a	100,000	direct

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

Rhythm Pharmaceuticals Inc Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Rhythm Pharmaceuticals Inc (RYTM)

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding RYTM (via 13F filings)

Filter by:

Mutual Funds Holding RYTM BETA

Active Schedule 13D and 13G filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

Elevate your investments